Ginkgo Bioworks Holdings annual depreciation and amortization
2019
2020
2021
2022
2023
2024
2025
Ginkgo Bioworks Holdings Depreciation & Amortization Growth & History (DNA)
Ginkgo Bioworks Holdings's depreciation and amortization was $59.0M for fiscal 2025.
View full Ginkgo Bioworks Holdings company overviewGinkgo Bioworks Holdings annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $59.0M | −$4.0M | −6.39% |
| 2024 | 2024-12-31 | $63.0M | −$7.5M | −10.62% |
| 2023 | 2023-12-31 | $70.5M | $28.0M | +65.70% |
| 2022 | 2022-12-31 | $42.6M | $13.5M | +46.35% |
| 2021 | 2021-12-31 | $29.1M | $15.2M | +109.72% |
| 2020 | 2020-12-31 | $13.9M | $3.1M | +28.91% |
| 2019 | 2019-12-31 | $10.8M | — | — |
Ginkgo Bioworks Holdings quarterly depreciation and amortization
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $12.3M | −$2.9M | −19.24% |
| Q1 2026 | 2026-03-31 | $12.8M | −$2.0M | −13.65% |
| Q4 2025 | 2025-12-31 | $13.7M | — | — |
| Q3 2025 | 2025-09-30 | $15.3M | −$1.9M | −11.14% |
| Q2 2025 | 2025-06-30 | $15.2M | −$2.1M | −12.01% |
| Q1 2025 | 2025-03-31 | $14.8M | $2.0M | +15.18% |
| Q3 2024 | 2024-09-30 | $17.2M | −$3.9M | −18.48% |
| Q2 2024 | 2024-06-30 | $17.3M | −$322,000 | −1.82% |
| Q1 2024 | 2024-03-31 | $12.9M | −$6.1M | −32.12% |
| Q3 2023 | 2023-09-30 | $21.1M | $12.1M | +136.18% |
| Q2 2023 | 2023-06-30 | $17.7M | $8.6M | +95.53% |
| Q1 2023 | 2023-03-31 | $19.0M | $10.0M | +112.06% |
| Q3 2022 | 2022-09-30 | $8.9M | $638,000 | +7.71% |
| Q2 2022 | 2022-06-30 | $9.0M | $1.9M | +26.00% |
| Q1 2022 | 2022-03-31 | $8.9M | $3.3M | +58.82% |
| Q3 2021 | 2021-09-30 | $8.3M | — | — |
| Q2 2021 | 2021-06-30 | $7.2M | — | — |
| Q1 2021 | 2021-03-31 | $5.6M | — | — |
Ginkgo Bioworks Holdings depreciation and amortization trends
Over the last five fiscal years, Ginkgo Bioworks Holdings's depreciation and amortization increased from $13.9M to $59.0M, a change of $45.1M. The latest reported quarter, Q2 2026, shows $12.3M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ginkgo Bioworks Holdings source filings ↗Community posts
Ginkgo joins a federally backed RNA-manufacturing project worth up to $17.5 million
Ginkgo Bioworks ($DNA) received a subcontract worth up to $17.5 million to participate in an ARPA-H program focused on RNA manufacturing. Waterfall Scientific is the prime contractor. The project, called ESCALATOR, is intended to combine co ...